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Link between high glucose  
and renin release
Diabetes mellitus, the metabolic syndrome, and obesity are 
abnormalities that cause many complications, including 
hypertension, proteinuria, and renal tissue injury. Researchers 
recently found a link between metabolism and cardiovascular 
regulation with the discovery that orphan G protein–coupled 
receptor (GPR91) functions as a receptor for the citric acid 
cycle intermediate succinate, and that succinate—which 
circulates in plasma—induces renin-dependent hyperten-
sion. GPR91 is present in many organs but is expressed most 
abundantly in the kidney. GPR91 has been detected in vari-
ous nephron segments and in the juxtaglomerular apparatus, 
yet the specific cellular localization remains undefined. A 
hallmark of early diabetes mellitus is activation of the renin–
angiotensin system (RAS), which may lead to hypertension 
and renal tissue injury. But the mechanism(s) of RAS activa-
tion is unclear. In a recent publication, Toma et al. identi-
fied succinate and its receptor GPR91 as the mechanism by 
which high levels of glucose directly trigger renin release. 
The signaling cascade involved the local accumulation of 
succinate by elevated glucose and activation of the kidney-
specific GPR91, located in the glomerular endothelium. The 
transduction pathway included endothelial Ca2+, the produc-
tion of nitric oxide and prostaglandin E2, and their paracrine 
actions on adjacent renin-producing cells. To examine the in 
vivo importance of GPR91 in diabetic and nondiabetic control 
animals, the authors used the streptozotocin model of diabetes 
and multiphoton imaging. As the figure shows, nondiabetic 
GPR91–/– mice (b) had reduced renin granular content in the 
juxtaglomerular apparatus as compared with GPR91+/+ litter-
mates (a); streptozotocin-diabetes in GPR91+/+ mice caused 
an increase in renin (c), which was reduced in GPR91–/– lit-
termates (d). Thus, activation of the GPR91 signaling cascade 
in diabetes is likely the cause of elevated renin and may be 
involved in the glomerular hyperfiltration characteristic of the 
early stages of this disease. More importantly, the succinate, 
GPR91, and renin cascade may provide a fruitful avenue of 
research on the link between metabolism and blood pressure. 
(J Clin Invest 2008; 118: 2526–2534; doi:10.1172/JCI33293)
Juan Oliver
Preeclampsia and the risk  
of end-stage renal disease
In recent years, a growing understanding has emerged about 
the effects of pregnancy-associated hypertension and diabetes 
mellitus on long-term maternal health. Now, a retrospective 
analysis examines the associations between preeclampsia and 
the development of end-stage renal disease (ESRD) in Nor-
way. Using the Norwegian Medical Birth Registry, as well as 
the Norwegian Renal Registry, Vikse et al. linked records to 
assess the association between preeclampsia as a risk factor 
and ESRD. Women who did not experience preeclampsia had 
rates of ESRD that did not vary significantly on the basis of 
the number of pregnancies that they had reported. Rates for 
women without preeclampsia were 3.3, 2.8, and 2.4 events 
per 100,000 person-years for one, two, and three pregnancies, 
respectively. In all cases, the occurrence of at least one episode 
of preeclampsia was associated with a higher rate of ESRD in 
relationships that directly related to the number of occur-
rences. Among women with one pregnancy and pre eclampsia, 
the rate of ESRD was 14.5 per 100,000 person-years at risk. 
Among women with two pregnancies, the rate was similar 
regardless of whether they experienced preeclampsia with one 
or both pregnancies (8.6 for the first pregnancy, 16.8 for the 
second pregnancy, and 15.4 for both pregnancies). Among 
women with three or more pregnancies, the rate of ESRD 
rose notably to 32.9 per 100,000 person-years if preeclampsia 
occurred in two or more of their pregnancies.
Preeclampsia was found to be more common among women 
with preexisting comorbidities that might predispose to ESRD. 
However, after adjustment for this confounding factor, the rel-
ative risk of ESRD with the exposure of preeclampsia is similar 
across all groups at ratios of 2.3 (1.3–4.1) to 5.3 (3.0–9.6). 
In this study, preeclampsia is associated with an increased 
risk of ESRD, although the evidence may not be strong 
enough to recommend that women with their first episode of 
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Renin granular content in GPR91+/+ and GPR91–/– mice in vivo. 
Representative images of juxtaglomerular apparatus renin content 
(green) in nondiabetic (a and b) and diabetic (c and d) GPR91+/+ (a and c) 
and GPR91–/– (b and d) mouse kidneys.
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preeclampsia avoid further pregnancies, which could affect 
their risk of ESRD. However, women who experience one epi-
sode of preeclampsia should receive vigilant lifelong screening 
for kidney disease, which could result in early treatment and 
better outcomes. (N Engl J Med 2008; 359: 800–809)
Lynda Szczech
Podocytes mediate the 
antiproteinuric effect  
of cyclosporine A
The immunosuppressive action of the calcineurin inhibitor 
cyclosporine A (CsA) is mediated by inhibition of nuclear fac-
tor of activated T cells (NFAT) signaling in T cells. However, 
CsA is also used for the treatment of proteinuric kidney dis-
eases, wherein its efficacy is unexpected. The antiproteinuric 
effect of CsA is attributed to its immunosuppressive action 
and used as evidence for the immunological pathogenesis of 
the disease. The common denominator in a variety of pro-
teinuric diseases, including minimal-change disease and focal 
segmental glomerulosclerosis, is podocyte dysfunction leading 
to loss of glomerular filter function and entry of protein into 
urine. It is now clear that dynamic regulation of the podocyte 
actin cytoskeleton is vital to normal kidney filter function, 
and mutations affecting several podocyte proteins lead to the 
rearrangement of the actin cytoskeleton and subsequent pro-
teinuria. Thus, proteins regulating podocyte actin dynamics are 
crucial for sustained glomerular filter function. In a recent and 
provocative study, Faul et al. reported that the beneficial effect 
of CsA on proteinuria is not dependent on NFAT inhibition 
but, rather, results from the stabilization of the actin cytoskel-
eton in kidney podocytes. They identified synaptopodin as a 
calcineurin-binding protein; in kidney and podocytes, these 
two proteins colocalized (Figure). In podocytes, CsA blocked 
the calcineurin-mediated dephosphorylation of synaptopodin, 
a regulator of Rho GTPases, thereby preserving the phospho-
rylation-dependent synaptopodin–14-3-3β interaction. Pres-
ervation of this interaction, in turn, protected synaptopodin 
from cathepsin L-mediated degradation. These interesting 
results unveil a new calcineurin signaling pathway that oper-
ates in podocytes and is essential for the maintenance of kid-
ney filter function. Hence, these findings open a new avenue of 
research on the treatment of proteinuric kidney diseases. (Nat 
Med 2008; 14: 931–938; doi:10.1038/nm.1857)
Juan Oliver
Expression of EpCAM  
is upregulated during  
regeneration of renal epithelia
The human epithelial cell adhesion molecule (hEpCAM) is 
involved in epithelial morphogenesis and repair of epithelial 
tissues. Investigators now hypothesize that changes in 
hEpCAM expression in vivo correlate with regeneration of 
renal epithelia after ischemia/reperfusion injury (IRi). Uni-
lateral IRi was performed on kidneys of hEpCAM transgenic 
mice. Trzpis et al. investigated changes in hEpCAM expression 
by quantitative RT-PCR in renal cortex and medulla dissected 
by laser dissection microscopy and assessed expression pat-
terns of hEpCAM in regenerating kidneys by immunohisto-
chemistry. The mechanism of hEpCAM promoter activation 
was investigated in vitro by real-time bioluminescent imaging 
in HK-2 cells and in primary tubular epithelial cells subjected 
to hypoxia and reoxygenation. In vivo, the transcription of 
the human EPCAM gene significantly increased in the renal 
cortex during tubular re-epithelialization. Also, the number 
of tubules that expressed hEpCAM protein more than doubled 
in the renal cortex during regeneration. De novo expression of 
hEpCAM was detected in the S1 segments of proximal tubules. 
Under hypoxic conditions in vitro, activity of the hEpCAM 
promoter was upregulated twofold in the HK-2 proximal epi-
thelial cell line. Moreover, both in primary proximal epithelial 
cells and in HK-2 cells, hEpCAM protein expression increased 
after hypoxia and reoxygenation. The authors propose that 
this upregulation of hEpCAM during postischemic renal 
regeneration in vivo and during in vitro hypoxia indicates that 
hEpCAM expression is associated with renal regeneration. 
(J Pathol 2008; 216: 201–208)
Marc De Broe
Synaptopodin and calcineurin in podocytes. In the adult mouse kidney 
(top) and differentiated cultured podocytes (bottom), calcineurin 
partially colocalizes with synaptopodin. Scale bars, 30 µm (top panels) 
and 25 µm (bottom panels).
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